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The phosphate/pyrophosphate translocase protein ('1"2) of the hepatic microsomal glucose-6-phosphatase syst m was 
identified and then purified using antibodies raised against the rat mitochondrial phosphate/hydroxyl ion antiport pro- 
tein. The T 2 protein was shown to be absent in the microsomes isolated from a patient previously diagnosed as having 
type Ic glycogen storage disease. 
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1. INTRODUCTION 
Hepatic microsomai glucose-6-phosphatase (EC 
3.1.3.9) catalyses a key step in the homeostatic 
regulation of blood glucose levels [1]. Substantial 
kinetic [2] and genetic evidence [3-5] indicates that 
glucose 6-phosphate hydrolysis is catalysed by a 
multicomponent system comprised of the 
glucose-6-phosphatase enzyme with its active site 
situated in the lumenal surface of the endoplasmic 
reticulum and three translocases which facilitate 
movement of glucose 6-phosphate (T1), phosphate 
and pyrophosphate (T2) and glucose (T3) between 
the cytosol and the lumen of the endoplasmic 
reticulum. The absence of any of these proteins 
will impair glucose 6-phosphate hydrolysis and 
cause type la, lb, lc or ld glycogen storage 
disease, respectively [5]. However, none of the 
transport proteins of the glucose-6-phosphatase 
system have been unequivocally identified or 
purified. 
Here, we identify and purify T2 the hepatic 
microsomal phosphate/pyrophosphate translocase 
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using antibodies raised against the rat mitochon- 
drial phosphate/hydroxyl ion antiport protein [6] 
and demonstrate that the hepatic microsomai T2 
protein is absent in an adult patient previously 
diagnosed as having type lc glycogen storage 
disease [5]. 
2. MATERIALS AND METHODS 
Biotinylated anti-rabbit antibody and streptavidin-linked 
peroxidase complex were purchased from Amersham (Amer- 
sham, England). 4-Chloro-l-naphthol, glucose 6-phosphate 
(monosodium salt), mannose 6-phosphate (monosodium salt) 
and prestained molecular mass markers were obtained from 
Sigma (Poole, England), Empigen BB was the kind gift of 
Albright and Wilson 0Vhitehaven, England). Nitrocellulose 
was obtained from Schieicher and Schuell (Dassell, FRG) and 
CNBr-activated Sepharose from Pharmacia (Uppsala). All 
other reagents were analytical reagent grade. 
2.1. Sample preparation 
Microsomes [6] and mitochondria [7] were prepared from the 
livers of starved Wistar rats as described. Samples of 
microsomes and mitochondria were prepared from fresh human 
liver biopsy samples as in [5]. Plasma membrane fragments 
were removed from preparations using agarose-bound Con- 
canavalin A as in [8]. Details of the patien t with type lc 
glycogen storage disease and control cases were l o given in 
[5]. Ethical approval was given by the Tayside Health Board 
Ethical Committee. 
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2.3. Assay of glucose-6-phosphatase 
Glucose-6-phosphatase and mannose-6-phosphatase ac- 
tivities were assayed as in [9] and are xpressed as/~mol Pi 
released/min per mg microsomal protein. Protein concentra- 
tions were measured bythe method of Peterson [10]. 
2.3. Antisera 
Polyclonal antisera to the rat liver mitochondria 
phosphate/hydroxyl ion antiport protein was raised in rabbits 
as described [7]. IgG was further purified by (NI-h)zSO4 frac- 
tionation as in [11]. Mitochondrial phosphate/hydroxyl ion an- 
tiport protein antibody-Sepharose columns were prepared using 
CNBr-Sepharose according to [12]. 
2.4. Immunoblot analysis 
Microsomal or mitoehondrial samples were subjected to lec- 
trophoresis on a 7-16% polyacrylamide gel as described by 
Laemmli [13] and silver stained [14] or electrophoretically 
transferred tonitrocellulose as in [15] or in the presence of 1°70 
Empigen BB [16] and visualised with antimitochondrial 
phosphate/hydroxyl ion antiport protein antibodies, a 
biotinylated anti-rabbit second antibody and a streptavidin- 
linked peroxidase complex as the detection system using 
4-chloro-naphthol as substrate. The molecular masses of the 
Sigma prestained standard proteins on the immunoblots were 
180, 116, 84, 58, 48.5, 36.5 and 26.6 kDa. The molecular 
masses of the Sigma standard proteins on the silver-stained gel 
were 66, 45, 36, 29, 24, 20.1 and 14.2 kDa. 
2.5. Purification of Tz 
Fresh microsomes were luted from a Concanavalin A col- 
umn and extracted in buffer A (0.5% Triton X-100, 20 mM 
LiCI, 0.1 mM EDTA, 0.5 mM dithiothreitol, 20raM 
phosphate, pH 7.0) and centrifuged at 105000 x g for I h. The 
pellet was resuspended in buffer A plus 8070 Triton X-100 and 
centrifuged at 105000 x g for 1 h. The supernatant was run 
through a Sephadex G-25M column to remove excess 
dithiothreitol before being applied to a phosphate/hydroxyl ion 
antiport protein antibody Sepharose column. After 1 h un- 
bound protein was washed off the column and the affinity- 
purified protein eluted by 1 M glycine, pH 4.0. 
3. RESULTS AND DISCUSSION 
3.1. Identification of  T2 
T2, the phosphate /pyrophosphate  t ransport  pro-  
tein of  the hepatic microsomal  glucose-6-phos- 
phatase  system has not been identif ied or pur i f ied 
nor  are any of  the known inhibitors of  T2 [17] 
specif ic enough to be used to identi fy the protein.  
Here,  we have used ant ibodies raised against 
another  phosphate t ransport  protein,  the rat 
hepat ic  mitochondr ia l  phosphate /hydroxy l  ion 
t ranspor t  protein,  to identi fy T2. 
The rabbit  ant ibody to the mitochondr ia l  
phosphate /hydroxy l  ion ant iport  protein was 
shown to be a specific ant ibody as it only cross- 
reacts with one polypept ide in immunoblot  
analysis of  control  human hepatic mi tochondr ia  
( f ig . l ,  lanes 4,5) and hepatic mitochondr ia  f rom 
pat ients with either type lb  or type lc glycogen 
storage disease ( f ig. l ,  lanes 2,3). In similar im- 
munob lots  o f  hepatic microsomes no cross- 
react ing bands were visualised (not shown). In 
these init ial immunoblot t ing studies proteins were 
t ransferred f rom SDS-polyacry lamide gels to 
nitrocel lulose essentially as described by Towbin et 
al. [15] and the proteins would therefore have been 
in a denatured state on the nitrocel lulose filters. 
These results therefore indicate that ant ibodies 
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Fig.1. lmmunoblot analysis of human hepatic mitochondria. 
Lanes: 1,6, prestained Sigma protein molecular mass tandards; 
2, human hepatic mitochondria from a patient with type lb 
glycogen storage disease (20/~g); 3, human hepatic 
mitochondria from a patient with type lc glycogen storage 
disease (20/~g); 4,5, control human hepatic mitochondria 
(2O/~g). 
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raised to the mitochondrial phosphate transport 
protein do not cross-react with the denatured T2 
protein. 
However, as both proteins transport phosphate 
it seemed possible that they might have some 
secondary structure similarities. Microsomal pro- 
teins were electrophoretically transferred from 
polyacrylamide gels to nitrocellulose .in the 
presence of 0.1 °70 of the zwitterionic detergent Em- 
pigen BB as described in [16] to allow partial 
renaturation of the proteins. Under these renatur- 
ing conditions the antibody cross-reacted with a 
single polypeptide in both rat (fig.2, lane 1) and 
human hepatic microsomes from control patients 
(fig.2, lanes 4,5,7). In contrast, the antibody's 
reaction with the mitochondrial phosphate/hy- 
droxyl ion antiport protein becomes much weaker 
after partial renaturation of the protein with Em- 
pigen BB (not shown). 
The identification of the immunoreactive 
polypeptide in microsomes as T2 was confirmed by 
the complete absence of a cross-reacting protein in 
the hepatic microsomes i olated from an adult pa- 
tient previously diagnosed [5] as having type lc 
glycogenosis which is caused by a deficiency to T2 
(fig.2, lane 6). The type lc glycogen storage patient 
had been shown (fig.l, lane 3) to have normal 
levels of the hepatic mitochondrial phosphate/ 
hydroxyl ion antiport protein, confirming that the 
cross-reacting band in microsomes was not due to 
Fig.2. Immunoblot analysis of rat and human hepatic 
microsomes. Lanes: 1, rat hepatic microsomes (10~g); 2,3,9, 
prestained Sigma protein molecular mass standards; 4,5,7, 
control human hepatic microsomes (20ag); 6, human hepatic 
microsomes from a patient with type lc glycogen storage 
disease (20/~g); 8, human hepatic microsomes from a patient 
with type lb glycogen storage disease (20/~g). 
Fig.3. SDS-polyacrylamide g l electrophoresis of purified rat 
hepatic microsomal T2. Lanes: 1, Sigma molecular mass 
standard proteins; 2-4, breakthrough from phosphate/ 
hydroxyl ion antiport protein antibody Sepharose column; 5-9, 
fractions eluted from a phosphate/hydroxyl ion antiport 
protein antibody Sepharose column at pH 4.0. 
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the presence of a mitochondrial contamination. 
The microsomal phosphate transport protein was 
also shown to be present in a patient with glycogen 
storage disease type lb which is a deficiency of TI, 
the hepatic microsomal glucose 6-phosphate 
transport protein confirming that Tt and T2 are in- 
deed different proteins. 
The subunit molecular mass of T2 is 37 kDa as 
judged by SDS-polyacrylamide g l electrophoresis 
(described in section 2). However, the apparent 
molecular mass varies somewhat depending on 
both the acrylamide concentration of the gel and 
the ionic strength of the buffer which suggests that 
T1 might be a glycoprotein. Unequivocal deter- 
mination of the exact molecular mass of T2 must 
therefore await the determination of the sequence 
of the characterised protein. In contrast, the 
mitochondrial phosphate/hydroxyl ion antiport 
protein has been shown not to be a glycoprotein 
and has a molecular mass of 34 kDa [7]. 
3.2. Purification of 7"2 
The ability to detect he T2 protein using im- 
munoblotting made it possible to devise a purifica- 
tion scheme for T2. T2 is an integral membrane 
protein and is not easily solubilised from the 
microsomal membrane. Rat hepatic microsomes 
were therefore xtracted in 0.5070 Triton X-100 (as 
detailed in section 2) which removes a large 
number of microsomal proteins and then 807o 
Triton X-100 was used to solubilise T2. The partial- 
ly purified T2 was then applied to a mitochondrial 
phosphate/hydroxyl ionand part protein antibody 
Sepharose column. The T2 protein was eluted with 
1 M glycine, pH 4.0, and was completely 
homogeneous a judged by silver staining of SDS- 
polyacrylamide g ls (fig.3). The purified protein is 
currently being used to raise polyclonal antiserum 
to T2 in sheep. 
The identification and purification of T2, the 
phosphate/pyrophosphate transport protein, have 
provided the necessary tools to approach the isola- 
tion of DNA probes for the protein which are re- 
quired to allow the prenatal diagnosis of type lc 
glycogen storage disease. 
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